Madison Greg 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Feb 16, 2018
Insider Transaction Report
Form 4
Madison Greg
See Remarks
Transactions
- Sale
Common Stock
2018-02-15$4.81/sh−15,318$73,680→ 414,086 total
Footnotes (2)
- [F1]Sale of a total of 15,318 shares of common stock was made in order to satisfy Mr. Madison's income tax withholding obligation upon the vesting of 50,001 shares of restricted stock on February 14, 2018. Mr. Madison had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 151,247 shares of restricted stock.